Porcilis Lawsonia ID vet.
Active substance
ATC code
Species
Pigs.
Indications
For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection.
Onset of immunity: 4 weeks after vaccination.
Duration of immunity: 21 weeks after vaccination.
Dose to be administered and administration route
Intradermal use.
Reconstitute the lyophilisate in the solvent or in Porcilis PCV ID as follows:
|
Lyophilisate |
Solvent for Porcilis Lawsonia ID or Porcilis PCV ID |
|
50 doses |
10 ml |
|
100 doses |
20 ml |
For proper reconstitution and correct administration, use the following procedure:
1. Allow the solvent or Porcilis PCV ID to reach room temperature and shake well before use.
2. Add approximately 5-10 ml of the solvent or Porcilis PCV ID to the lyophilisate vial and mix briefly.
3. Withdraw the reconstituted concentrate from the vial and transfer it back into the vial with the solvent or the Porcilis PCV ID. Shake briefly to mix.
4. Use the vaccine suspension within 6 hours of reconstitution. Any vaccine remaining at the end of this time should be discarded.
Avoid introduction of a contamination by multiple broaching.
Dosage:
A single dose of 0.2 ml of reconstituted vaccine in pigs starting at 3 weeks of age.
Vaccinate pigs by the intradermal route using a multi-dose needle-free injection device for intradermal application of liquids suitable to deliver a “jet-stream” volume of vaccine (0.2ml ± 10%) through the epidermal layers of the skin.
Safety and efficacy of Porcilis Lawsonia ID have been demonstrated using the device IDAL.
Visual appearance after reconstitution: homogenous white to nearly white emulsion after shaking.
Adverse reactions
|
Very common (>1 animal / 10 animals treated): |
Elevated temperature1 and injection site swelling2 |
1 Mean increase of 0.1 °C, up to 1.4 °C in individual pigs. The animals return to normal temperature within 1 day after vaccination.
2 Mean diameter of approximately 1 cm, in individual pigs up to 5 cm. Injection site swelling disappear within 4 weeks after vaccination.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for respective contact details.
